# ADAM29

## Overview
ADAM29 is a gene that encodes the ADAM metallopeptidase domain 29 protein, a member of the ADAM (A Disintegrin and Metalloproteinase) family. This family of proteins is characterized by their membrane-anchored structure and involvement in various biological processes, including cell adhesion and signaling. Although ADAM29 lacks proteolytic activity due to the absence of a critical zinc-binding motif, it plays a significant role in integrin-mediated cell adhesion, particularly as a ligand for integrin α4 (Wang2017Multiple; Przemyslaw2013ADAM). The gene is predominantly expressed in the testis, indicating a potential role in spermatogenesis and reproductive functions (EDWARDS2008The). ADAM29 is also implicated in several cancers, where its expression levels and mutations are associated with disease progression and prognosis, highlighting its potential as a therapeutic target (Wei2011Analysis; Chen2018Clinical).

## Structure
ADAM29 is a member of the ADAM (A Disintegrin and Metalloproteinase) family, characterized by a modular structure that includes several distinct domains. The protein typically comprises a pro-domain, a metalloprotease domain, a disintegrin domain, a cysteine-rich domain, and an EGF-like domain (EDWARDS2008The). The metalloprotease domain is part of the metzincin clan, featuring a globular structure with two subdomains and an active site cleft. The N-terminal subdomain contains a twisted, 5-stranded beta-pleated sheet, while the lower subdomain houses the catalytic Zn-binding site, crucial for its proteolytic activity (EDWARDS2008The).

The disintegrin domain, although lacking the RGD sequence typical of snake venom disintegrins, plays a role in cell adhesion and interaction with integrins (EDWARDS2008The). The cysteine-rich domain is involved in protein interactions and regulation of ADAM function (EDWARDS2008The). ADAM29 is primarily expressed in the testis, suggesting a role in spermatogenesis (EDWARDS2008The).

Post-translational modifications of ADAM29 may include glycosylation and phosphorylation, which are common in ADAM family proteins. The gene can produce alternatively spliced transcripts, resulting in variant proteins with potentially distinct functions (EDWARDS2008The).

## Function
ADAM29 is a member of the ADAM (A Disintegrin and Metalloproteinase) family, which are membrane-anchored proteins involved in various biological processes. Unlike many other ADAM proteins, ADAM29 does not exhibit proteolytic activity due to the absence of a high-conservative zinc-binding motif, which is essential for catalytic function (Przemyslaw2013ADAM). Despite its lack of enzymatic activity, ADAM29 plays a role in integrin-mediated cell adhesion. It functions as a ligand for integrin α4, supporting cell adhesion processes that are crucial for cellular interactions and signaling (Wang2017Multiple).

ADAM29 is primarily expressed in the testis, suggesting a role in reproductive processes, potentially related to spermatogenesis and sperm function (EDWARDS2008The). The gene encodes multiple splice variants, which differ in the 5'-untranslated region, although the specific functions of these isoforms in healthy cells remain unclear (Brocker2009Evolutionary). The protein's involvement in cell adhesion and its expression pattern indicate that it may contribute to the regulation of cell-to-cell and cell-to-matrix interactions, which are essential for maintaining tissue structure and function. However, the precise molecular mechanisms and organismal outcomes of ADAM29's activity in healthy human cells are not fully understood.

## Clinical Significance
ADAM29 is implicated in various cancers due to mutations and altered expression levels. In melanoma, ADAM29 is frequently mutated, with somatic mutations found in over 15% of cases. These mutations, particularly in the propeptide and reprolysin domains, enhance cell adhesion to collagen, potentially driving melanoma progression (Wei2011Analysis). In gastric cancer, ADAM29 expression is significantly elevated in tumor tissues compared to normal tissues. Higher expression levels correlate with advanced cancer stages and poorer survival outcomes, promoting proliferation, migration, and invasion of cancer cells (Chen2018Clinical).

ADAM29 is also overexpressed in esophageal cancer, where it is associated with tumor metastasis and advanced clinical stages. Its expression can predict the transformation from precancerous lesions to esophageal carcinoma (Wang2020Expression). In chronic lymphocytic leukemia (CLL), the LPL/ADAM29 expression ratio serves as a prognostic marker, with higher ADAM29 expression linked to a more favorable prognosis in mutated CLL cases (Oppezzo2005The). These findings suggest that ADAM29 plays a significant role in cancer progression and could serve as a potential target for therapeutic intervention.


## References


[1. (Wang2017Multiple) Lei Wang, Jason A. Hoggard, Erica D. Korleski, Gideon V. Long, Brandy C. Ree, Kenneth Hensley, Stephen R. Bond, Tyra G. Wolfsberg, JianMing Chen, Tonya N. Zeczycki, and Lance C. Bridges. Multiple non-catalytic adams are novel integrin α4 ligands. Molecular and Cellular Biochemistry, 442(1–2):29–38, September 2017. URL: http://dx.doi.org/10.1007/s11010-017-3190-y, doi:10.1007/s11010-017-3190-y. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11010-017-3190-y)

[2. (Wang2020Expression) Tingting Wang, Xiaoyan Lv, Shen Jiang, Shaorong Han, and Yanming Wang. Expression of adam29 and fam135b in the pathological evolution from normal esophageal epithelium to esophageal cancer: their differences and clinical significance. Oncology Letters, January 2020. URL: http://dx.doi.org/10.3892/ol.2020.11272, doi:10.3892/ol.2020.11272. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2020.11272)

[3. (EDWARDS2008The) D EDWARDS, M HANDSLEY, and C PENNINGTON. The adam metalloproteinases. Molecular Aspects of Medicine, 29(5):258–289, October 2008. URL: http://dx.doi.org/10.1016/j.mam.2008.08.001, doi:10.1016/j.mam.2008.08.001. This article has 875 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.mam.2008.08.001)

[4. (Przemyslaw2013ADAM) Leszczynski Przemyslaw, Hendrich Andrzej Boguslaw, Szmida Elzbieta, and Sasiadek Maria Malgorzata. Adam and adamts family proteins and their role in the colorectal cancer etiopathogenesis. BMB Reports, 46(3):139–150, March 2013. URL: http://dx.doi.org/10.5483/bmbrep.2013.46.3.176, doi:10.5483/bmbrep.2013.46.3.176. This article has 36 citations and is from a peer-reviewed journal.](https://doi.org/10.5483/bmbrep.2013.46.3.176)

[5. (Chen2018Clinical) Hongbing Chen and Siping Wang. Clinical significance of adam29 promoting the invasion and growth of gastric cancer cells in�vitro. Oncology Letters, May 2018. URL: http://dx.doi.org/10.3892/ol.2018.8838, doi:10.3892/ol.2018.8838. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2018.8838)

[6. (Oppezzo2005The) P. Oppezzo. The lpl/adam29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood, 106(2):650–657, July 2005. URL: http://dx.doi.org/10.1182/blood-2004-08-3344, doi:10.1182/blood-2004-08-3344. This article has 105 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2004-08-3344)

[7. (Wei2011Analysis) Xiaomu Wei, Angela Moncada-Pazos, Santiago Cal, Clara Soria-Valles, Jared Gartner, Udo Rudloff, Jimmy C. Lin, Steven A. Rosenberg, Carlos López-Otín, and Yardena Samuels. Analysis of the disintegrin-metalloproteinases family reveals adam29 and adam7 are often mutated in melanoma. Human Mutation, 32(6):E2148–E2175, February 2011. URL: http://dx.doi.org/10.1002/humu.21477, doi:10.1002/humu.21477. This article has 32 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.21477)

[8. (Brocker2009Evolutionary) Chad N Brocker, Vasilis Vasiliou, and Daniel W Nebert. Evolutionary divergence and functions of the adam and adamts gene families. Human Genomics, 4(1):43, 2009. URL: http://dx.doi.org/10.1186/1479-7364-4-1-43, doi:10.1186/1479-7364-4-1-43. This article has 76 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1479-7364-4-1-43)